Nicola Silvestris - Concepedia

Author

Nicola Silvestris

Also Known As

Carlo Salvarani, Mario Scartozzi, Massimo Costantini, N Silvestris, N. Silvestris, Nicola Silvestris, Nicola Silvestris (477360), Nicola Steele, On the behalf of the “dynamic medicine OECI group”, S. Nicola

525

Publications

13.4K

Citations

H-Index

141

Concepts

All Affiliations

Istituto Tumori Bari Istituti di Ricovero e Cura a Carattere Scientifico University of Bari Aldo Moro Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori University of Cagliari

About

Nicola Silvestris is an author at Istituto Tumori Bari specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	50	2K
2	Health Sciences	7	7	192
3	Public Health	4	4	59
4	Arts	1	1	57
5	Engineering	1	1	23

Nicola Silvestris

129

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 Khanh Bao Tran, Justin J. Lang, Kelly Compton, The Lancet	2022	886
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini, The Lancet Oncology OncologyMedicineColorectal CancerPathologyUpfront Folfoxiri	2020	309
Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study Jinfeng Huang, Jianfei Shen, Xiao Li, Annals of Translational Medicine	2020	205
Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine Gianmauro Numico, Ornella Garrone, Vincenzo Dongiovanni, Cancer	2005	197
Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells Amalia Azzariti, Rosa Maria Iacobazzi, R. Fonte, Scientific Reports	2019	153
Hospital Admission of Cancer Patients: Avoidable Practice or Necessary Care? Gianmauro Numico, Antonella Cristofano, Alessandro Mozzicafreddo, PLoS ONE	2015	139
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study Daniele Santini, Marco Tampellini, Bruno Vincenzi, Annals of Oncology Surgical OncologyGastrointestinal OncologyMedicineNatural HistoryColorectal Cancer	2012	129
Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma Jie Chu, Fei Ge, Bo Zhang, Journal of Experimental & Clinical Cancer Research	2013	107
High density of tryptase‐positive mast cells in human colorectal cancer: a poor prognostic factor related to protease‐activated receptor 2 expression Andrea Malfettone, Nicola Silvestris, Concetta Saponaro, Journal of Cellular and Molecular Medicine High DensityTumor BiologyCancer ImmunosurveillanceOncologyMc Density	2013	100
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib Andrea Casadei‐Gardini, Emanuela Scarpi, Luca Faloppi, Oncotarget PrognosisImmunologyPathologySystemic Immune-inflammation IndexAdvanced Hcc Patients	2016	94

Page 1